- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-Q Quarterly report
- 10.4 Exhibit 10.4 Indemnification Agreement Dated November 1, 2020 with James Sapirstein
- 10.5 Exhibit 10.5 Indemnification Agreement Dated November 1, 2020 with Terry Brostowin
- 10.6 Exhibit 10.6 Indemnification Agreement Dated November 1, 2020 with Bruce Harmon
- 31.1 Exhibit 31.1 Section 302 Certification
- 31.2 Exhibit 31.2 Section 302 Certification
- 32.1 Exhibit 32.1 Section 906 Certification
- 32.2 Exhibit 32.2 Section 906 Certification
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
I, James Sapirstein, Executive Chairman of Marizyme, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 16, 2020 | By: | /s/ James Sapirstein |
|
| James Sapirstein Executive Chairman (Principal Executive Officer) |